Sickle cell patients to have quicker and more accessible treatment in England

Government announces £9m funding to make specialist blood machines more widely available across NHS

People living with sickle cell disease in England are to benefit from quicker and more accessible treatment due to a £9m investment, the government has announced.

Apheresis services, which are a type of treatment that removes harmful components from a patient’s blood, are to improve across England through the funding of more specialist treatment centres. The funding will ensure the wider availability of machines that remove a patient’s sickled red blood cells and replace them with healthy donor cells.